“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: PP.05 Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

€3.03

SKU: product-article-15590 Category: General

Description
Reviews (0)

Description

PP.05 Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Top

Article: PP.05 Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura

Description

Reviews

Related products

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in respiratory oncology

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in urologic cancer